Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 NOK | 0.00% | -8.76% | -55.04% |
Sales 2023 | 354K 33.21K | Sales 2024 * | - | Capitalization | 489M 45.84M |
---|---|---|---|---|---|
Net income 2023 | -190M -17.83M | Net income 2024 * | -195M -18.29M | EV / Sales 2023 | 1,670 x |
Net cash position 2023 | 156M 14.68M | Net Debt 2024 * | 70.86M 6.65M | EV / Sales 2024 * | - |
P/E ratio 2023 |
-2.14
x | P/E ratio 2024 * |
-1.73
x | Employees | 25 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 91.97% |
Latest transcript on BerGenBio ASA
1 week | -8.76% | ||
Current month | -13.79% | ||
1 month | -24.88% | ||
3 months | -42.92% | ||
6 months | -25.77% | ||
Current year | -55.04% |
Managers | Title | Age | Since |
---|---|---|---|
Martin Olin
CEO | Chief Executive Officer | 55 | 21-09-07 |
Rune Skeie
DFI | Director of Finance/CFO | 51 | 18-03-04 |
Cristina Oliva
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sally Bennett
BRD | Director/Board Member | 52 | 20-12-08 |
Sveinung Hole
BRD | Director/Board Member | 57 | 10-08-31 |
Chairman | 63 | 22-01-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 0.125 | +2.29% | 26,800,110 |
24-05-14 | 0.1222 | -7.42% | 93,168,290 |
24-05-13 | 0.132 | -4.90% | 45,807,440 |
24-05-10 | 0.1388 | +1.31% | 18,908,850 |
24-05-08 | 0.137 | -1.58% | 74,570,050 |
Real-time Oslo Bors, May 15, 2024 at 10:45 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.04% | 44.15M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- BGBIO Stock